Erratum to: Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys (Nature Communications, (2018), 9, 1, (4324), 10.1038/s41467-018-06657-5);Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Michael, Edwin ^a   Smith, Morgan E ^a   Katabarwa, Moses N ^b   Byamukama, Edson ^c   Grisworld, Emily ^b   Habomugisha, Peace ^c   Lakwo, Thomson ^d   Tukahebwa, Edridah ^d   Miri, Emmanuel S ^e   Eigege, Abel ^e   Ngige, Evelyn ^f   Unnasch, Thomas R ^g   Richards, Frank O ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b EMORY UNIVERSITY   (United States)

^c Carter Center Uganda   (Uganda)

^d MINISTRY OF HEALTH   (Uganda)

^e CARTER CENTER   (United States)

^f Federal Ministry of Health   (Nigeria)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN;

DECISION MAKING; DISEASE CONTROL; FILARIASIS; INFECTIOUS DISEASE; ONCHOCERCIASIS; PARASITE TRANSMISSION; PARASITIC DISEASE; SURVEY METHOD;

ARTICLE; CALCULATION; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DECISION MAKING; DIAGNOSTIC TEST; DISEASE ELIMINATION; HEALTH SURVEY; HUMAN; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NIGERIA; ONCHOCERCIASIS; PARASITE CLEARANCE; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITOSIS; PREDICTION; PROBABILITY; UGANDA; BIOLOGICAL MODEL; PARASITOLOGY; QUESTIONNAIRE; SAMPLE SIZE; TRANSMISSION;

NIGERIA; UGANDA;

ELEPHANTIASIS, FILARIAL; HUMANS; MODELS, BIOLOGICAL; ONCHOCERCIASIS; PARASITIC DISEASES; SAMPLE SIZE; SURVEYS AND QUESTIONNAIRES; UGANDA;

EID: 85055073546     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-07507-0     Document Type: Erratum

References (71)

1. Cochi, S. L., Hegg, L., Kaur, A., Pandak, C. & Jafari, H. The global polio eradication initiative: progress, lessons learned, and polio legacy transition planning. Health Aff. 35, 277–283 (2016)
2. Raviglione, M. et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379, 1902–1913 (2012)
3. WHO. Global malaria control and elimination: report of a technical review. ISBN 978 92 4 159675 6 (2008)
4. WHO. Accelerating work to overcome the global impact of neglected tropical diseases - a roadmap for implementation. WHO/HTM/NTD/2012.1 (2012)
5. Klepac, P., Metcalf, C. J., McLean, A. R. & Hampson, K. Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philos. Trans. R. Soc. A 368, 20120137 (2013)
6. Singh, B. K. & Michael, E. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, lymphatic filariasis. Parasite Vector 8, 1–26 (2015)
7. Sunish, I. P. et al. Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia--a longitudinal study. Trop. Med. Int. Health 7, 59–69 (2002)
8. Cameron, A. R. & Baldock, F. C. A new probability formula for surveys to substantiate freedom from disease. Prev. Vet. Med. 34, 1–17 (1998)
9. Cameron, A. R. & Baldock, F. C. Two-stage sampling in surveys to substantiate freedom from disease. Prev. Vet. Med. 34, 19–30 (1998)
10. Martin, R. A. J., Cameron, A. R. & Greiner, M. Demonstrating freedom from disease using multiple complex data sources 1: a new methodology based on scenario trees. Prev. Vet. Med. 79, 71–97 (2007)
11. Sergeant E. Epitools epidemiological calculators. http://epitools.ausvet.com.au. (2017)
12. Ziller, M., Selhorst, T., Teuffert, J., Kramer, M. & Schlüter, H. Analysis of sampling strategies to substantiate freedom from disease in large areas. Prev. Vet. Med. 52, 333–343 (2002)
13. Anderson R. M., May R. M. Infectious Diseases of Humans. Dynamics and Control (Oxford Univ. Press, 1991)
14. Duerr, H. P., Dietz, K. & Eichner, M. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 21, 88–96 (2005)
15. Gambhir, M. & Michael, E. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis. PLoS ONE 3, e2874 (2008)
16. Michael, E., Malecela-Lazaro, M. N., Kabali, C., Snow, L. C. & Kazura, J. W. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 22, 226–233 (2006)
17. Michael, E., Malecela-Lazaro, M. N. & Kazura, J. W. Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. Adv. Parasit. 65, 191–237 (2007)
18. Cameron A. R. Survey Toolbox for Aquatic Animal Diseases. A Practical Manual and Software Package (ACIAR, 2002)
19. Cameron A. Principles for the Design and Conduct of Surveys to Show Presence or Absence of Infectious Disease in Aquatic Animals (AusVet Animal Health Services Pty Ltd, 2004)
20. Michael, E., Malecela-Lazaro, M. N., Maegga, B. T., Fischer, P. & Kazura, J. W. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 22, 529–535 (2006)
21. WHO. Strengthening the assessment of lymphatic filariasis transmission and documenting the achievement of elimination. WHO/HTM/NTD/PCT/2016.09 (2016)
22. WHO. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. WHO/APOC/MG/10.1 (2010)
23. Cannon, R. M. & Roe, R. T. Livestock Disease Surveys: A Field Manual for Veterinarians. Australian Bureau of Animal Health. (Australian Government Publishing Service, Australia, Canberra, 1982)
24. Gambhir, M. et al. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol. 8, 22 (2010)
25. Michael, E. & Singh, B. K. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis. BMC Med. 14, 1 (2016)
26. Singh, B. K. et al. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS ONE 8, e67004 (2013)
27. Stolk, W. A., Walker, M., Coffeng, L. E., Basanez, M. G. & de Vlas, S. J. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasite Vector 8, 552 (2015)
28. Reimer, L. J. et al. Insecticidal bed nets and filariasis transmission in Papua New Guinea. New Engl. J. Med 369, 745–753 (2013)
29. Richards, F. O. et al. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS Negl. Trop. Dis. 5, e1346 (2011)
30. Vlaminck, J., Fischer, P. U. & Weil, G. J. Diagnostic tools for onchocerciasis elimination programs. Trends Parasitol. 31, 571–582 (2015)
31. Taylor, H. R., Munoz, B., Keyvanlarijani, E. & Greene, B. M. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am. J. Trop. Med. Hyg. 41, 467–471 (1989)
32. Bottomley, C. et al. Modelling neglected tropical diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasite Vector 9, 343 (2016)
33. Boatin, B. A. et al. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 125, 545–552 (2002)
34. Weil, G. J., Lammie, P. J. & Weiss, N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol. Today 13, 401–404 (1997)
35. Irvine, M. A. et al. Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection. Trans. R. Soc. Trop. Med. Hyg. 110, 118–124 (2016)
36. Chandrasena, T. G. A. N., Premaratna, R., Abeyewickrema, W. & de Silva, N. R. Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka. Trans. R. Soc. Trop. Med. Hyg. 96, 60–63 (2002)
37. Stresman, G., Cameron, A. & Drakeley, C. Freedom from Infection: confirming Interruption of Malaria Transmission. Trends Parasitol. 33, 345–352 (2017)
38. Dukpa, K., Robertson, I. D. & Ellis, T. M. Serological and clinical surveillance studies to validate reported foot-and-mouth disease free status in Tsirang district of Bhutan. Prev. Vet. Med. 104, 23–33 (2012)
39. Rao, R. U. et al. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration. PLoS Negl. Trop. Dis. 8, e3281 (2014)
40. Rao, R. U. et al. Programmatic use of molecular xenomonitoring at the Level of evaluation units to assess persistence of lymphatic filariasis in Sri Lanka. PLoS. Negl. Trop. Dis. 10, e0004722 (2016)
41. WHO. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. WHO/HTM/NTD/PCT/2016.1 (2016)
42. Cannon, R. M. Sense and sensitivity—designing surveys based on an imperfect test. Prev. Vet. Med. 49, 141–163 (2001)
43. Hester S., Sergeant E., Herbert K., Robinson A. Post-border surveillance techniques: review, synthesis and deployment. Australian Centre of Excellence for Risk Analysis (ACERA) Report 1004 (University of Melbourne, 2012)
44. Johnson, W. O., Su, C.-L., Gardner, I. A. & Christensen, R. Sample size calculations for surveys to substantiate freedom of populations from infectious agents. Biometrics 60, 165–171 (2003)
45. Weil, G. J. & Ramzy, R. M. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 23, 78–82 (2007)
46. Anderson, D. P. et al. Development of integrated surveillance systems for the management of tuberculosis in New Zealand wildlife. New Zeal Vet. J. 63, 89–97 (2015)
47. Pedersen, E. M., Stolk, W. A., Laney, S. J. & Michael, E. The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis. Trends Parasitol. 25, 319–327 (2009)
48. Madden, L. V. & Hughes, G. Sampling for plant disease incidence. Phytopathology 89, 1088–1103 (1999)
49. Madden L. V., Hughes G., Bosch F. The Study of Plant Disease Epidemics (American Phytopathological Society (APS Press), 2007)
50. Madden, L. V., Hughes, G. & Munkvold, G. P. Plant disease incidence: Inverse sampling, sequential sampling, and confidence intervals when observed mean incidence is zero. Crop. Prot. 15, 621–632 (1996)
51. Onsager J. A. The Rationale of Sequential Sampling, with Emphasis on its Use in Pest Management (US Department of Agriculture, Agricultural Research Service, 1976)
52. Waters, W. E. Sequential sampling in forest insect surveys. For. Sci. 1, 68–79 (1955)
53. Venette, R. C., Moon, R. D. & Hutchison, W. D. Strategies and statistics of sampling for rare individuals. Annu. Rev. Entomol. 47, 143–174 (2002)
54. Binns M. R., Nyrop J. P., van der Werf W. Sampling and Monitoring in Crop Protection. The Theoretical Basis for Developing Practical Decision Guides (CABI Publishing, 2000)
55. London Declaration on Neglected Tropical Diseases: Ending the neglect and reaching 2020 goals. http://unitingtocombatntds.org/london-declaration-neglected-tropical-diseases (2012)
56. Anderson, D. P. et al. A novel approach to assess the probability of disease eradication from a wild-animal reservoir host. Epidemiol. Infect. 141, 1509–1521 (2013)
57. Schuppers, M. E. et al. A study to demonstrate freedom from Trichinella spp. in domestic pigs in Switzerland. Zoonoses Public Health 57, e130–e135 (2010)
58. Basanez, M. G. & Boussinesq, M. Population biology of human onchocerciasis. Philos. Trans. R. Soc. B 354, 809–826 (1999)
59. Filipe, J. A. N. et al. Human infection patterns and heterogeneous exposure in river blindness. Proc. Natl Acad. Sci. USA 102, 15265–15270 (2005)
60. Duerr, H. P., Dietz, K., Schulz-Key, H., Buttner, D. W. & Eichner, M. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 97, 242–250 (2003)
61. Gambhir, M., Singh, B. K. & Michael, E. The Allee effect and elimination of neglected tropical diseases: a mathematical modelling study. Adv. Parasit. 97, 1–37 (2015)
62. Snow, L. C. & Michael, E. Transmission dynamics of lymphatic filariasis: density‐dependence in the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes. Med. Vet. Entomol. 16, 409–423 (2002)
63. Michael, E. et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect. Dis. 4, 223–234 (2004)
64. Walker, M. et al. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal. Epidemics 18, 4–15 (2017)
65. Spear, R. C., Hubbard, A., Liang, S. & Seto, E. Disease transmission models for public health decision making: toward an approach for designing intervention strategies for Schistosomiasis japonica. Environ. Health Persp 110, 907–915 (2002)
66. Smith, M. E., Singh, B. K. & Michael, E. Assessing endgame strategies for the elimination of lymphatic filariasis: a model-based evaluation of the impact of DEC-medicated salt. Sci. Rep. 7, 7386 (2017)
67. Katabarwa, M. et al. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. Am. J. Trop. Med. Hyg. 90, 1159–1166 (2014)
68. Loum, D. et al. Evaluation of community-directed operation of black fly traps for entomological surveillance of Onchocerca volvulus transmission in the Madi-Mid North focus of onchocerciasis in Northern Uganda. Am. J. Trop. Med. Hyg. 97, 1235–1242 (2017)
69. Slater, H. & Michael, E. Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling. PLoS ONE 7, e32202 (2012)
70. Michael, E. et al. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020. BMC Med. 15, 176 (2017)
71. Wald, A. Sequential tests of statistical hypotheses. Ann. Math. Stat. 16, 117–186 (1945)